Terms: = Kidney tumors AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824 AND Diagnosis
64 results:
1. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
2. Update on Selected High-grade Renal Cell Carcinomas of the kidney: FH-deficient, ALK-rearranged, and Medullary Carcinomas.
Chen YB
Adv Anat Pathol; 2024 Mar; 31(2):118-125. PubMed ID: 38145398
[TBL] [Abstract] [Full Text] [Related]
3. Tazemetostat in the therapy of pediatric ini1-negative malignant rhabdoid tumors.
Vejmelkova K; Pokorna P; Noskova K; Faustmannova A; Drabova K; Pavelka Z; Bajciova V; Broz M; Tinka P; Jezova M; Palova H; Kren L; Valik D; Slaby O; Sterba J
Sci Rep; 2023 Dec; 13(1):21623. PubMed ID: 38062114
[TBL] [Abstract] [Full Text] [Related]
4. Extracranial malignant rhabdoid tumors in children: high mortality even with the help of an aggressive clinical approach.
Xie S; Fang Y; Yang Y; Liu L; Bai J; Lin S; Zhang B; Fang Y
Eur J Pediatr; 2024 Feb; 183(2):557-567. PubMed ID: 38019286
[TBL] [Abstract] [Full Text] [Related]
5. Genomic alterations and diagnosis of renal cancer.
Zhang X; Bolck HA; Rupp NJ; Moch H
Virchows Arch; 2024 Feb; 484(2):323-337. PubMed ID: 37999735
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic challenges of renal medullary carcinoma and the role for cytologic assessment: Case report and literature review.
Severseike BO; Schafernak KT; Willard SD; Goncalves LF; Kothari AK; Eshun FK; Mangum R
J Clin Lab Anal; 2023 Apr; 37(4):e24854. PubMed ID: 36843202
[TBL] [Abstract] [Full Text] [Related]
7. New insights in the new WHO classification of adult renal tumors.
Hes O; Michalová K; Pivovarčíková K
Cesk Patol; 2022; 67(4):187-191. PubMed ID: 36513503
[TBL] [Abstract] [Full Text] [Related]
8. How New Developments Impact diagnosis in Existing Renal Neoplasms.
Akgul M; Williamson SR
Surg Pathol Clin; 2022 Dec; 15(4):695-711. PubMed ID: 36344184
[TBL] [Abstract] [Full Text] [Related]
9. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
Sahu DK; Singh N; Das M; Rawat J; Gupta DK
Pediatr Surg Int; 2022 Nov; 38(11):1601-1617. PubMed ID: 36107237
[TBL] [Abstract] [Full Text] [Related]
10. [Analysis of 18 cases of malignant rhabdoid tumor in children].
Yin CY; Wang YC; Du WC; Liu YF
Zhonghua Er Ke Za Zhi; 2022 Sep; 60(9):908-914. PubMed ID: 36038300
[No Abstract] [Full Text] [Related]
11. Malignant rhabdoid tumor: Cyto-histologic correlation and immunohistochemical characterization of a rare pediatric malignancy and its differential diagnoses.
Kerper AL; Clarke-Brodber AL; Gupta S; Whalen KM; Nigdelioglu R; Boland JM; Schembri Wismayer DJ; Torres-Mora J; Mejia Acevedo MR; Sudhindran V; Sturgis CD
Ann Diagn Pathol; 2022 Oct; 60():152014. PubMed ID: 35905536
[TBL] [Abstract] [Full Text] [Related]
12. Extracranial rhabdoid tumours: Results of a SFCE series of patients treated with a dose compression strategy according to European Paediatric Soft tisue sarcoma Study Group recommendations.
Enault M; Minard-Colin V; Corradini N; Leverger G; Thebaud E; Rome A; Proust S; Marie-Cardine A; Defachelles AS; Sarnacki S; Philippe-Chomette P; Delattre O; Masliah-Planchon J; Lacour B; Ferrari A; Brennan B; Orbach D; Bourdeaut F
Eur J Cancer; 2022 Jan; 161():64-78. PubMed ID: 34929472
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma.
Wilson NR; Wiele AJ; Surasi DS; Rao P; Sircar K; Tamboli P; Shah AY; Genovese G; Karam JA; Wood CG; Tannir NM; Msaouel P
Clin Genitourin Cancer; 2021 Dec; 19(6):e401-e408. PubMed ID: 34625389
[TBL] [Abstract] [Full Text] [Related]
14. [smarcb1(ini1)-deficient renal cell carcinoma: medullary and beyond : Evolving concepts].
Agaimy A; Hartmann A
Pathologe; 2021 Nov; 42(6):571-577. PubMed ID: 34609565
[TBL] [Abstract] [Full Text] [Related]
15. Undifferentiated and dedifferentiated urological carcinomas: lessons learned from the recent developments.
Agaimy A; Hartmann A; Trpkov K; Hes O
Semin Diagn Pathol; 2021 Nov; 38(6):152-162. PubMed ID: 34579992
[TBL] [Abstract] [Full Text] [Related]
16. EZR-ROS1 fusion renal cell carcinoma mimicking urothelial carcinoma: report of a previously undescribed gene fusion in renal cell carcinoma.
Tatjana A; Tjota MY; O'Donnell PH; Eggener SE; Agarwal PK; Haridas R; Segal J; Wang P
Virchows Arch; 2022 Feb; 480(2):487-492. PubMed ID: 34128116
[TBL] [Abstract] [Full Text] [Related]
17. Proceedings of the North American Society of Head and Neck Pathology, Baltimore, MD, March 17, 2021: The Mistakes I Made When I Stepped Out of My Neck of the Woods.
Khan MS; Malhotra A; Prasad ML
Head Neck Pathol; 2021 Mar; 15(1):113-119. PubMed ID: 33723763
[TBL] [Abstract] [Full Text] [Related]
18. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Trpkov K; Hes O; Williamson SR; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Gill AJ
Mod Pathol; 2021 Jul; 34(7):1392-1424. PubMed ID: 33664427
[TBL] [Abstract] [Full Text] [Related]
19. Cytomorphological and immunohistochemical features of renal and extrarenal rhabdoid tumors.
D P; Sadasivan B; Patil Okaly GV; MukundaPai M; Alashetty S; B L K
Diagn Cytopathol; 2021 Jun; 49(6):711-717. PubMed ID: 33638610
[TBL] [Abstract] [Full Text] [Related]
20. Pediatric Renal tumors: Updates in the Molecular Era.
Treece AL
Surg Pathol Clin; 2020 Dec; 13(4):695-718. PubMed ID: 33183728
[TBL] [Abstract] [Full Text] [Related]
[Next]